meta_pixel
Tapesearch Logo
Log in
Nutrition Facts with Dr. Greger

What’s a Safer and Cheaper Way to Lose Weight Than GLP-1 Drugs

Nutrition Facts with Dr. Greger

[email protected]

Health & Fitness, Alternative Health, Nutrition

4.83.6K Ratings

🗓️ 21 August 2025

⏱️ 13 minutes

🧾️ Download transcript

Summary

Tackling the root cause of obesity
This episode features audio from Obesity: Is a GLP-1 Deficiency Its Cause, and How to Treat It Without Ozempic and Other Drugs
Visit the video page for all sources and doctor's notes related to this podcast.
 
 

Transcript

Click on a timestamp to play from that location

0:00.0

Have you ever wondered if there are more natural ways to lower your high blood pressure,

0:05.5

guard against Alzheimer's, lose weight, feel better?

0:08.4

Well, it turns out there is.

0:11.9

Welcome to the Nutrition Facts podcast.

0:14.5

I'm your host, Dr. Michael Greger.

0:16.5

Today we have the final episode in our series on OZembek, and we ask,

0:21.0

what's a safer and cheaper way to lose weight than GOP1 drugs?

0:26.6

Can we drug our way out of the obesity crisis?

0:30.7

Are these GOP1 drugs the answer to the obesity epidemic?

0:34.1

The head of the European Association for the study of obesity was pretty bullish,

0:38.1

conveniently failing to disclose that his group had received millions of dollars from the drug maker.

0:44.2

But doesn't getting a tiny weekly injection sound far easier than getting all sweaty in the gym?

0:50.6

Do these game-changing new medications make lifestyle-based treatment of obesity obsolete?

0:57.0

Let's ask those paid by the two main GLP-1 drug makers, which now have a combined net worth

1:02.4

greater than a trillion dollars.

1:04.9

The World Obesity Federation, which evidently just got a million dollars from the Ozemic

1:09.4

company, published a consensus

1:11.3

statement in one of its journals favoring the definition of obesity as a disease.

1:16.7

This designation may not benefit patients, but it will benefit doctors and drug companies

1:21.4

when health insurance and clinical guidelines promote treatment with drugs and surgery.

1:25.7

A concern is that labeling obesity as a disease

1:28.6

risks reducing our autonomy, disempowering and robbing us with the intrinsic motivation

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from [email protected], and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of [email protected] and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2025.